title: New lung cancer drugs from bradykinin antagonists.
authors.affiliation: Department of Biochemistry, University of Colorado Health Sciences Center, Denver, CO 80262, USA. john.stewart@uchsc.edu
authors.forename: John M
authors.initials: JM
authors.lastname: Stewart
authors.forename: Lajos
authors.initials: L
authors.lastname: Gera
authors.forename: Daniel C
authors.initials: DC
authors.lastname: Chan
authors.forename: Eunice J
authors.initials: EJ
authors.lastname: York
authors.forename: Laimute T
authors.initials: LT
authors.lastname: Stewart
authors.forename: Vitalija
authors.initials: V
authors.lastname: Simkeviciene
authors.forename: Barbara
authors.initials: B
authors.lastname: Helfrich
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000737:chemistry / Q000627:therapeutic use*; D001920:Bradykinin / Q000037:antagonists & inhibitors*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D004354:Drug Screening Assays, Antitumor; D008175:Lung Neoplasms / Q000188:drug therapy*; D051379:Mice; D008819:Mice, Nude
chemical_list: D000970:Antineoplastic Agents; D001920:Bradykinin